Today: 8 June 2026
Mortgage Rates Today: 30-Year Loan Holds Near 2026 Highs as Homebuilder Stocks Rebound
23 March 2026
2 mins read

Mortgage Rates Today: 30-Year Loan Holds Near 2026 Highs as Homebuilder Stocks Rebound

NEW YORK, March 23, 2026, 14:25 EDT

Mortgage rates in the U.S. dipped just slightly on Monday. Mortgage News Daily’s daily index showed the top-tier 30-year fixed rate coming in at 6.49%—that’s a minor decline of 4 basis points, or 0.04 percentage point, from Friday’s level. Freddie Mac’s latest weekly survey, as of March 19, still reported the benchmark 30-year fixed at 6.22%.

Borrowing costs remain a headwind for affordability right as the spring selling season picks up. U.S. construction spending slid 0.3% in January. Outlays for new single-family projects dipped 0.2%. Sales of new homes tumbled 17.6%, dropping to a 587,000 annualized rate—the lowest seen since October 2022.

Bonds took the spotlight Monday. Early on, oil tumbled as much as 13%, and yields on the 10-year Treasury slipped by up to 8.7 basis points before leveling out, following President Donald Trump’s announcement to delay U.S. strikes on Iranian power plants. Fiona Cincotta of City Index called it a shift in pricing around “worst-case expectations.” Mortgage News Daily noted a moderate uptick in MBS—those mortgage-backed securities—potentially giving some lenders room to lower rates before the session wrapped. Reuters

Still, the day-to-day reading is outpacing last week’s official survey figure. Freddie Mac’s weekly number tracks conventional, conforming purchase loans—20% down, top-tier credit—spanning Thursday to Wednesday. Mortgage News Daily, on the other hand, updates its lender index every business day. That gap makes Monday’s daily rate noticeably higher than the Freddie Mac average reported for March 19.

“The 30-year fixed-rate mortgage ticked higher to 6.22% this week, but still sits about half a point below where it stood a year ago,” said Sam Khater, chief economist at Freddie Mac, on Thursday. Khater noted buyers are heading into a “more affordable spring homebuying season than last,” with both purchase applications and pending sales on the rise. Freddie Mac

Still, there’s only so much optimism to go around. Pending home sales climbed 1.8% in February, but that bump came before the Iran flare-up sent rates higher again. Hannah Jones, a senior economic research analyst at Realtor.com, flagged possible “headwinds” for the spring market—Middle East tensions, inflation, and changing tariffs all in the mix. Reuters

Homebuilder stocks climbed along with the broader market. D.R. Horton picked up 4.6% in afternoon trading, Lennar advanced 4.1%, and PulteGroup was up 3.9% as Wall Street bounced and oil prices eased, drawing buyers back to names that had been under pressure.

The risk remains. On Friday, Matthew Graham at Mortgage News Daily noted that the average lender rate pushed past 6.5%—matching levels last seen on Sept. 3, 2025. Hopes for a consistent drop below 6% like in February? “Highly unlikely” anytime soon, Graham said, even if the war wraps up quickly. Mortgage News Daily

Borrowers are getting mixed signals this week. Sure, rates have backed off their sharpest intraday spikes, yet they’re still sitting well above the 5.98% mark logged right before the war began. A renewed climb in oil or another jump in Treasury yields could squeeze affordability further, right as buyers and builders head into the peak season.

Stock Market Today

  • Markets Jitter Over Iran Conflict, AI Bubble Risks, Fed Rate Hikes, and SpaceX IPO
    June 8, 2026, 6:02 AM EDT. Markets face heightened volatility as renewed Iran-Israel tensions raise geopolitical risks. Strong U.S. jobs data suggest the Federal Reserve may hike interest rates further, dampening growth prospects. Recent weak guidance from Broadcom signals a potential AI tech bubble burst, triggering a tech selloff. Adding fuel, SpaceX's highly anticipated IPO could prompt investors to raise cash, potentially increasing market turbulence. Futures on the Dow, S&P 500, and Nasdaq all declined slightly, while oil prices surged over 2.5%, reflecting geopolitical concerns. Investors remain cautious as upcoming inflation reports may influence future Federal Reserve policy and market direction.

Latest articles

Asia Markets: Kospi Selloff Hits AI Shares in Region

Asia Markets: Kospi Selloff Hits AI Shares in Region

8 June 2026
South Korea’s KOSPI plunged 8.3%—triggering circuit breakers—as investors dumped AI chip stocks like Samsung Electronics (-10.2%) and SK Hynix (-7.7%) amid surging oil prices and revived Fed rate-hike bets, exposing Asia’s heavy reliance on a handful of tech giants and raising fresh risks for crowded trades.
Keel Stock in Focus Monday After $400M AI Debt Raise

Keel Stock in Focus Monday After $400M AI Debt Raise

8 June 2026
Keel Infrastructure shares rose 3.1% to $5.29 in pre-market trading after pricing an upsized $400 million convertible note deal to fund AI data-center expansion, partially recovering from Friday’s 13.5% drop driven by dilution concerns; the company aims to use proceeds for equipment deposits and hedging, with investors watching for future lease signings as the next key milestone.
MPS Shares Surge After Intesa Launches €30.6 Billion Offer

MPS Shares Surge After Intesa Launches €30.6 Billion Offer

8 June 2026
Banca Monte dei Paschi di Siena shares soared 10.91% to 9.921 euros after Intesa Sanpaolo launched an unsolicited €30.6 billion cash-and-share bid, offering a 12.5% premium and triggering takeover rules that block MPS from merging with Banco BPM without shareholder approval, as investors weigh regulatory hurdles, branch disposals, and the fight for control of key Italian financial assets.
Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

Hyperscale Data Stock Faces 21-Cent Deadline After Friday’s 25% Slide

8 June 2026
Hyperscale Data’s $0.21/share buyback offer sits 39% above Friday’s $0.1510 close, with the tender expiring late Monday and covering up to 5.1% of shares; the company cites a “material disconnect” with net book value at $0.26/share, while ending its ATM stock-sale program and holding $51.8M in Bitcoin as of May 31.
Zealand Pharma Shares Sink 25% After Trial Results

Zealand Pharma Shares Sink 25% After Trial Results

8 June 2026
Zealand Pharma shares plunged 26.02% to 241.40 Danish crowns after investors focused on a 19% discontinuation rate for Boehringer’s obesity drug survodutide in the SYNCHRONIZE-1 trial, far higher than the 2.9% for placebo, despite strong fat-loss data, making the stock the worst performer on Europe’s STOXX 600 in early trade.
Dow Jones Price Today: Index Jumps Nearly 900 Points as Oil Tumbles on Iran Pause
Previous Story

Dow Jones Price Today: Index Jumps Nearly 900 Points as Oil Tumbles on Iran Pause

Coeur Mining stock rises as New Gold deal boosts 2026 output, $750 million buyback
Next Story

Coeur Mining stock rises as New Gold deal boosts 2026 output, $750 million buyback

Go toTop